Although intravitreal bevacizumab has become an increasingly popular therapy for ROP over the past 5 years, more must be learned about its long-term safety and effectiveness.
By R.V. Paul Chan, MD, MSc, FACS
By David S. Boyer, MD
Staining agents and steroids can improve visualization of membranes intraoperatively.
By Brian C. Joondeph, MD, FACS
By Richard Latuska; Neelema Sinha, MD; and Carol L. Shields, MD
The technology is providing previously unavailable insights into choroidal pathologies.
Reviewed by Richard F. Spaide, MD